// App-Quantinova.ai

1518 : Prospective registry of multiplex testing (PROMPT): A web-based platform to assess cancer risk of genetic variants.

Researchers

Presenter

  • Michael Francis Walsh

Principal Investigators

  • Pragna Gaddam

  • Laura Digiovanni

  • Judith Balmana

  • Jill S Dolinsky

  • Taylor Sittler

  • Rachel Klein

  • Stephen E Lincoln

  • Brian Allen

  • Justin Leighton

  • Charles Strom

  • Vanessa Ranger-Miller

  • Kyle Brown

  • Judy Ellen Garber

  • Fergus J. Couch

  • Susan M. Domchek

  • Mark E. Robson

  • Kenneth Offit

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer, New York, NY

  • University of Pennsylvania, Philadelphia, PA

  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain

  • Ambry Genetics, Aliso Viejo, CA

  • Color Genomics, Burlingame, CA

  • GeneDx, Gaithersburg, MD

  • InVitae, San Francisco, CA

  • Myriad Genetics, Inc., Salt Lake City, UT

  • Pathway Genomics, San Diego, CA

  • Quest Diagnostics Nichols Institute, San Juan Capistrano, CA

  • PatientCrossroads, San Mateo, CA

  • Dana-Farber Cancer Institute, Boston, MA

  • Mayo Clinic, Rochester, MN

  • University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

Locations

  • United States

  • Spain

Companies

  • Myriad Genetics, Inc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved